Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Genollá

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Medicina Clinica|March 22, 1986
[Tumor markers and pleural effusions]A Ruibal, J Genollá
Gut|July 1, 1993
Serum concentrations of laminin in cirrhosis of the liverJ Collazos, F Díaz, J Genollá
The International Journal of Biological Markers|July 1, 1991
CA 15.3 in nonmalignant liver diseasesJ Collazos, J Genollá, A Ruibal
Clinical Chemistry|April 1, 1991
Neuron-specific enolase concentrations in serum in benign liver diseasesJ Collazos, J Genollá, A Ruibal
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disordersJ Collazos, J Genollá, A Ruibal
The Clinical Investigator|May 1, 1993
Study of serum procollagen type III peptide in patients with hepatic cirrhosis from a clinical point of viewF Díaz, J Collazos, J Genollá
Digestion|January 1, 1992
A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosisJ Collazos, J Genollá, A Ruibal
Journal of Clinical Gastroenterology|March 1, 1994
Serum laminin levels offer only a little additional information in liver diseaseF Díaz, J Collazos, J Genollá
American Journal of Respiratory and Critical Care Medicine|July 1, 1994
Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseasesJ Collazos, C Esteban, A Fernández, et al.
Medicina Clinica|March 21, 1987
[Serum CA 15.3-ELSA in non-tumor pathology]A Ruibal, J Genollá, M Rosell, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Medicina Clinica|March 22, 1986
[Tumor markers and pleural effusions]A Ruibal, J Genollá
Gut|July 1, 1993
Serum concentrations of laminin in cirrhosis of the liverJ Collazos, F Díaz, J Genollá
The International Journal of Biological Markers|July 1, 1991
CA 15.3 in nonmalignant liver diseasesJ Collazos, J Genollá, A Ruibal
Clinical Chemistry|April 1, 1991
Neuron-specific enolase concentrations in serum in benign liver diseasesJ Collazos, J Genollá, A Ruibal
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disordersJ Collazos, J Genollá, A Ruibal
The Clinical Investigator|May 1, 1993
Study of serum procollagen type III peptide in patients with hepatic cirrhosis from a clinical point of viewF Díaz, J Collazos, J Genollá
Digestion|January 1, 1992
A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosisJ Collazos, J Genollá, A Ruibal
Journal of Clinical Gastroenterology|March 1, 1994
Serum laminin levels offer only a little additional information in liver diseaseF Díaz, J Collazos, J Genollá
American Journal of Respiratory and Critical Care Medicine|July 1, 1994
Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseasesJ Collazos, C Esteban, A Fernández, et al.
Medicina Clinica|March 21, 1987
[Serum CA 15.3-ELSA in non-tumor pathology]A Ruibal, J Genollá, M Rosell, et al.
Pageof 3